Quick Answer
CytoMed Therapeutics Ltd reported Total Assets of $6.21 million for the year ending 2025.
- CytoMed Therapeutics Ltd showed a decrease of -38.3% in Total Assets from 2024 to 2025.
- This data is from CytoMed Therapeutics Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), CytoMed Therapeutics Ltd's Total Assets has grown by 2.1%.
- Historical annual values: Fiscal year 2025: $6.21 million | Fiscal year 2024: $10.07 million | Fiscal year 2023: $12.37 million | Fiscal year 2022: $5.23 million | Fiscal year 2021: $6.08 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: